Nilsson M, Wielanek L, Wang J-S, Tanner K E, Lidgren L
Biomaterials and Biomechanics Lab, Department of Orthopaedics, BMC-C12, S-221 84 Lund, Sweden.
J Mater Sci Mater Med. 2003 May;14(5):399-404. doi: 10.1023/a:1023254632704.
A biphasic injectable bone substitute, suitable for filling bone defects, that sets in the body, based on calcium sulfate and hydroxyapatite (HA), is presented. For applications in bone defects the compressive strength is important to assure support of the defect site during loading when the patient is weight bearing. To control the strength, the influence of four different factors; the liquid-to-powder (L/P) ratio, the HA particle morphology, the HA content and the amount of accelerator, were investigated. alpha-Calcium sulfate hemihydrate (CSH) and four different HA powders (three sintered and one spray-dried) were used. All differed in size and morphology. CSH and each HA powder were mixed together with distilled water to form the bone substitute. An accelerator, in form of calcium sulfate dihydrate, was added to the powder phase to obtain an adequate setting time. Cylindrical specimens were compression tested. A lower L/P-ratio gave stronger cement, but was more difficult to inject. The shape and the morphology of the HA particles influenced the strength, and reducing the amount of HA increased the strength. The amount of accelerator (calcium sulfate dihydrate) had no influence.
本文介绍了一种基于硫酸钙和羟基磷灰石(HA)的双相可注射骨替代物,适用于填充骨缺损,可在体内凝固。对于骨缺损应用而言,抗压强度对于确保患者负重时缺损部位在加载过程中得到支撑非常重要。为了控制强度,研究了四个不同因素的影响:液粉比(L/P)、HA颗粒形态、HA含量和促进剂用量。使用了α-半水硫酸钙(CSH)和四种不同的HA粉末(三种烧结粉末和一种喷雾干燥粉末)。所有粉末在尺寸和形态上均有差异。将CSH与每种HA粉末与蒸馏水混合以形成骨替代物。向粉末相中添加二水硫酸钙形式的促进剂以获得适当的凝固时间。对圆柱形试样进行压缩测试。较低的L/P比可使骨水泥更强,但注射难度更大。HA颗粒的形状和形态影响强度,减少HA用量可提高强度。促进剂(二水硫酸钙)用量没有影响。